[
  {
    "ts": "2026-01-26T01:51:00+00:00",
    "headline": "2 AI Stocks to Buy in January and Hold for 5 Years",
    "summary": "Artificial intelligence (AI) spending is growing fast, and these blue-chip tech stocks can help you profit from it.",
    "url": "https://www.fool.com/investing/2026/01/25/2-ai-stocks-to-buy-in-january-and-hold-for-5-years/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "71e0657f-a5dd-374f-b16c-9b7784e2304a",
      "content": {
        "id": "71e0657f-a5dd-374f-b16c-9b7784e2304a",
        "contentType": "STORY",
        "title": "2 AI Stocks to Buy in January and Hold for 5 Years",
        "description": "",
        "summary": "Artificial intelligence (AI) spending is growing fast, and these blue-chip tech stocks can help you profit from it.",
        "pubDate": "2026-01-26T01:51:00Z",
        "displayTime": "2026-01-26T01:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e5ea218fb06da7a7c9041c19adeb077c",
          "originalWidth": 1400,
          "originalHeight": 894,
          "caption": "Microsoft logo.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/h9PQqo0gTaUoZIkBllHSlg--~B/aD04OTQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/e5ea218fb06da7a7c9041c19adeb077c.cf.webp",
              "width": 1400,
              "height": 894,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LaI8WgdEoShiDheHkI2Isg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e5ea218fb06da7a7c9041c19adeb077c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/25/2-ai-stocks-to-buy-in-january-and-hold-for-5-years/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-ai-stocks-buy-january-015100847.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-26T05:29:00+00:00",
    "headline": "The AI Stock With a Monster Revenue Backlog Heading Into 2026",
    "summary": "Oracle's backlog grew by $68 billion in the company's second quarter of fiscal 2026.",
    "url": "https://www.fool.com/investing/2026/01/26/the-ai-stock-with-a-monster-revenue-backlog-headin/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f7e6d049-df8e-3f0e-9714-be484ef99943",
      "content": {
        "id": "f7e6d049-df8e-3f0e-9714-be484ef99943",
        "contentType": "STORY",
        "title": "The AI Stock With a Monster Revenue Backlog Heading Into 2026",
        "description": "",
        "summary": "Oracle's backlog grew by $68 billion in the company's second quarter of fiscal 2026.",
        "pubDate": "2026-01-26T05:29:00Z",
        "displayTime": "2026-01-26T05:29:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/2cd473ef9f3d7d9d4bd48a91ab70a35e",
          "originalWidth": 1400,
          "originalHeight": 787,
          "caption": "Three coworkers stand in front of a large computer screen. They are discussing the reports on the screen.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hlSu5uJtAYHqgssPZHE6.Q--~B/aD03ODc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/2cd473ef9f3d7d9d4bd48a91ab70a35e.cf.webp",
              "width": 1400,
              "height": 787,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pwdCaYjtSUxhw290w8c3VA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/2cd473ef9f3d7d9d4bd48a91ab70a35e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/26/the-ai-stock-with-a-monster-revenue-backlog-headin/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ai-stock-monster-revenue-backlog-052900408.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-26T13:00:00+00:00",
    "headline": "Voisin Consulting to Advance Pharmacovigilance Capabilities with Oracle",
    "summary": "Voisin Consulting Life Sciences (VCLS), a well-established contract research organization (CRO) with a focus on unmet medical need and rare drug clinical trials, has chosen Oracle Argus to significantly enhance its global pharmacovigilance operations. By choosing Argus, VCLS will gain proven tools to enhance and deliver comprehensive, end-to-end pharmacovigilance services to its diverse global clientele.",
    "url": "https://finance.yahoo.com/news/voisin-consulting-advance-pharmacovigilance-capabilities-130000283.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "738add39-9f2f-3056-a61a-159ac8ed800e",
      "content": {
        "id": "738add39-9f2f-3056-a61a-159ac8ed800e",
        "contentType": "STORY",
        "title": "Voisin Consulting to Advance Pharmacovigilance Capabilities with Oracle",
        "description": "",
        "summary": "Voisin Consulting Life Sciences (VCLS), a well-established contract research organization (CRO) with a focus on unmet medical need and rare drug clinical trials, has chosen Oracle Argus to significantly enhance its global pharmacovigilance operations. By choosing Argus, VCLS will gain proven tools to enhance and deliver comprehensive, end-to-end pharmacovigilance services to its diverse global clientele.",
        "pubDate": "2026-01-26T13:00:00Z",
        "displayTime": "2026-01-26T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/67c05716b5a602f07373eea3f949608e",
          "originalWidth": 400,
          "originalHeight": 124,
          "caption": "(PRNewsfoto/Oracle)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FyEzKPsQVw3UFR9MMoMLGg--~B/aD0xMjQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/67c05716b5a602f07373eea3f949608e.cf.webp",
              "width": 400,
              "height": 124,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L68aJnDhdgMy3.jfT0FHBw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/67c05716b5a602f07373eea3f949608e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/voisin-consulting-advance-pharmacovigilance-capabilities-130000283.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/voisin-consulting-advance-pharmacovigilance-capabilities-130000283.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-26T14:00:08+00:00",
    "headline": "Investors Heavily Search Oracle Corporation (ORCL): Here is What You Need to Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Oracle (ORCL). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finance.yahoo.com/news/investors-heavily-search-oracle-corporation-140008570.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8d0c36fc-c275-352d-b814-34215845a013",
      "content": {
        "id": "8d0c36fc-c275-352d-b814-34215845a013",
        "contentType": "STORY",
        "title": "Investors Heavily Search Oracle Corporation (ORCL): Here is What You Need to Know",
        "description": "",
        "summary": "Recently, Zacks.com users have been paying close attention to Oracle (ORCL). This makes it worthwhile to examine what the stock has in store.",
        "pubDate": "2026-01-26T14:00:08Z",
        "displayTime": "2026-01-26T14:00:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c",
          "originalWidth": 900,
          "originalHeight": 602,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pvuz17CX7uZXP_M4m07aNg--~B/aD02MDI7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c.cf.webp",
              "width": 900,
              "height": 602,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WI_MXYsPrWUgMadr2DDsiw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investors-heavily-search-oracle-corporation-140008570.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-heavily-search-oracle-corporation-140008570.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]